334 related articles for article (PubMed ID: 22187729)
1. Time course of improvement with antipsychotic medication in treatment-resistant schizophrenia.
Suzuki T; Remington G; Arenovich T; Uchida H; Agid O; Graff-Guerrero A; Mamo DC
Br J Psychiatry; 2011 Oct; 199(4):275-80. PubMed ID: 22187729
[TBL] [Abstract][Full Text] [Related]
2. Effect size of symptom status in withdrawal of typical antipsychotics and subsequent clozapine treatment in patients with treatment-resistant schizophrenia.
Pickar D; Bartko JJ
Am J Psychiatry; 2003 Jun; 160(6):1133-8. PubMed ID: 12777272
[TBL] [Abstract][Full Text] [Related]
3. Trajectories of response to treatment with atypical antipsychotic medication in patients with schizophrenia pooled from 6 double-blind, randomized clinical trials.
Stauffer V; Case M; Kollack-Walker S; Ascher-Svanum H; Ball T; Kapur S; Kinon BJ
Schizophr Res; 2011 Aug; 130(1-3):11-9. PubMed ID: 21489754
[TBL] [Abstract][Full Text] [Related]
4. Effectiveness of second-generation antipsychotics in patients with treatment-resistant schizophrenia: a review and meta-analysis of randomized trials.
Chakos M; Lieberman J; Hoffman E; Bradford D; Sheitman B
Am J Psychiatry; 2001 Apr; 158(4):518-26. PubMed ID: 11282684
[TBL] [Abstract][Full Text] [Related]
5. Switching to Clozapine Using Immediate Versus Gradual Antipsychotic Discontinuation: A Pilot, Double-Blind, Randomized Controlled Trial.
Takeuchi H; Lee J; Fervaha G; Foussias G; Agid O; Remington G
J Clin Psychiatry; 2017 Feb; 78(2):223-228. PubMed ID: 28234436
[TBL] [Abstract][Full Text] [Related]
6. Childhood-onset schizophrenia: A double-blind, randomized clozapine-olanzapine comparison.
Shaw P; Sporn A; Gogtay N; Overman GP; Greenstein D; Gochman P; Tossell JW; Lenane M; Rapoport JL
Arch Gen Psychiatry; 2006 Jul; 63(7):721-30. PubMed ID: 16818861
[TBL] [Abstract][Full Text] [Related]
7. Relationship between clinical improvement and functional gains with clozapine in schizophrenia.
Lee J; Takeuchi H; Fervaha G; Bhaloo A; Powell V; Remington G
Eur Neuropsychopharmacol; 2014 Oct; 24(10):1622-9. PubMed ID: 25156578
[TBL] [Abstract][Full Text] [Related]
8. Initial severity of schizophrenia and efficacy of antipsychotics: participant-level meta-analysis of 6 placebo-controlled studies.
Furukawa TA; Levine SZ; Tanaka S; Goldberg Y; Samara M; Davis JM; Cipriani A; Leucht S
JAMA Psychiatry; 2015 Jan; 72(1):14-21. PubMed ID: 25372935
[TBL] [Abstract][Full Text] [Related]
9. Improvement of negative and positive symptoms in treatment-refractory schizophrenia: a double-blind, randomized, placebo-controlled trial with memantine as add-on therapy to clozapine.
de Lucena D; Fernandes BS; Berk M; Dodd S; Medeiros DW; Pedrini M; Kunz M; Gomes FA; Giglio LF; Lobato MI; Belmonte-de-Abreu PS; Gama CS
J Clin Psychiatry; 2009 Oct; 70(10):1416-23. PubMed ID: 19906345
[TBL] [Abstract][Full Text] [Related]
10. Add-on of aripiprazole improves outcome in clozapine-resistant schizophrenia.
De Risio A; Pancheri A; Simonetti G; Giannarelli D; Stefanutto L; Gentile B
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jun; 35(4):1112-6. PubMed ID: 21447367
[TBL] [Abstract][Full Text] [Related]
11. A double-blind comparative study of clozapine and risperidone in the management of severe chronic schizophrenia.
Azorin JM; Spiegel R; Remington G; Vanelle JM; Péré JJ; Giguere M; Bourdeix I
Am J Psychiatry; 2001 Aug; 158(8):1305-13. PubMed ID: 11481167
[TBL] [Abstract][Full Text] [Related]
12. Randomized controlled trial of effect of prescription of clozapine versus other second-generation antipsychotic drugs in resistant schizophrenia.
Lewis SW; Barnes TR; Davies L; Murray RM; Dunn G; Hayhurst KP; Markwick A; Lloyd H; Jones PB
Schizophr Bull; 2006 Oct; 32(4):715-23. PubMed ID: 16540702
[TBL] [Abstract][Full Text] [Related]
13. Risperidone versus clozapine in treatment-resistant chronic schizophrenia: a randomized double-blind study. The Risperidone Study Group.
Bondolfi G; Dufour H; Patris M; May JP; Billeter U; Eap CB; Baumann P
Am J Psychiatry; 1998 Apr; 155(4):499-504. PubMed ID: 9545995
[TBL] [Abstract][Full Text] [Related]
14. Augmentation of clozapine with a second antipsychotic--a meta-analysis of randomized, placebo-controlled studies.
Taylor DM; Smith L
Acta Psychiatr Scand; 2009 Jun; 119(6):419-25. PubMed ID: 19245679
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of two alternative schizophrenia remission definitions: relationship to clinical and quality of life outcomes.
Dunayevich E; Sethuraman G; Enerson M; Taylor CC; Lin D
Schizophr Res; 2006 Sep; 86(1-3):300-8. PubMed ID: 16860974
[TBL] [Abstract][Full Text] [Related]
16. A quantitative review of the profile and time course of symptom change in schizophrenia treated with clozapine.
Sherwood M; Thornton AE; Honer WG
J Psychopharmacol; 2012 Sep; 26(9):1175-84. PubMed ID: 22465946
[TBL] [Abstract][Full Text] [Related]
17. An open comparison of clozapine and risperidone in treatment-resistant schizophrenia.
Flynn SW; MacEwan GW; Altman S; Kopala LC; Fredrikson DH; Smith GN; Honer WG
Pharmacopsychiatry; 1998 Jan; 31(1):25-9. PubMed ID: 9524981
[TBL] [Abstract][Full Text] [Related]
18. Equipercentile linking of the BPRS and the PANSS.
Leucht S; Rothe P; Davis JM; Engel RR
Eur Neuropsychopharmacol; 2013 Aug; 23(8):956-9. PubMed ID: 23433639
[TBL] [Abstract][Full Text] [Related]
19. Early improvement on antipsychotic treatment as a predictor of subsequent response in schizophrenia: analyses from ziprasidone clinical studies.
O'Gorman C; Kapur S; Kolluri S; Kane J
Hum Psychopharmacol; 2011; 26(4-5):282-90. PubMed ID: 21638329
[TBL] [Abstract][Full Text] [Related]
20. Clinical relevance of findings in trials of antipsychotics: systematic review.
Lepping P; Sambhi RS; Whittington R; Lane S; Poole R
Br J Psychiatry; 2011 May; 198(5):341-5. PubMed ID: 21525517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
